Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) EBITDA Margin (2019 - 2024)

Intelligent Bio Solutions has reported EBITDA Margin over the past 6 years, most recently at 378.94% for Q1 2024.

  • Quarterly results put EBITDA Margin at 378.94% for Q1 2024, up 102784.0% from a year ago — trailing twelve months through Mar 2024 was 355.87% (up 6860.0% YoY), and the annual figure for FY2023 was 828.97%, down 28807.0%.
  • EBITDA Margin for Q1 2024 was 378.94% at Intelligent Bio Solutions, down from 248.83% in the prior quarter.
  • Over the last five years, EBITDA Margin for INBS hit a ceiling of 18.36% in Q4 2022 and a floor of 9885.81% in Q1 2021.
  • Median EBITDA Margin over the past 5 years was 638.38% (2020), compared with a mean of 1349.3%.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 21283192bps in 2020 and later tumbled -800558bps in 2021.
  • Intelligent Bio Solutions' EBITDA Margin stood at 691.26% in 2020, then crashed by -181bps to 1944.12% in 2021, then skyrocketed by 99bps to 18.36% in 2022, then crashed by -1256bps to 248.83% in 2023, then plummeted by -52bps to 378.94% in 2024.
  • The last three reported values for EBITDA Margin were 378.94% (Q1 2024), 248.83% (Q4 2023), and 306.9% (Q3 2023) per Business Quant data.